One of the key strategies the NFL and NFLPA are utilizing during the 2020 season to prevent the spread of COVID-19 is a testing program to help identify, treat and isolate infected individuals. To perform the testing, the NFL and NFLPA have partnered with BioReference Laboratories (BRL), which uses a national system of laboratories separate from local health care resources. The tests they are performing are the most sensitive, reliable and accurate tests available with a 24-hour turnaround time for results.
Click here to download a PDF version of the NFL-NFLPA COVID-19 Testing & Treatment Protocols fact sheet.
Testing is just one component of the comprehensive effort to mitigate risk of COVID-19 during the 2020 season. Other efforts include the overhaul of club facilities to accommodate physical distancing, around-the-clock cleaning and disinfection, a modernized system of contact tracing, and behavior-based changes, like virtual meetings, mask-wearing and avoiding large gatherings.
Two types of tests are being used:
- Molecular tests for COVID-19 diagnosis (PCR tests): To quickly identify active infections in the team environment and help limit the spread of COVID-19, these mandatory tests were used for Intake Testing and are being used for Ongoing Monitoring Testing. These tests have a 24-hour turnaround time for results.
- Antibody tests for COVID-19 exposure: These tests, which are voluntary, are used to indicate prior infection with the COVID-19 virus. Players who are positive for antibodies will receive additional cardiac screening.
Tier Designations & Testing Schedule
Keeping players protected from the virus is the number one priority of the NFL and NFLPA’s joint protocols. Not all individuals require the same level of access, therefore all club personnel have been assigned a tier designation and corresponding testing schedule.
- Tier 1: Players and essential football personnel whose job function requires direct access to players on a regular basis.
- Tier 2: Essential personnel who may need to be in close proximity to players and other Tier 1 Individuals and who may need to access Restricted Areas periodically.
- Tier 3: Individuals who do not require close proximity to Tier 1 individuals, but perform essential facility, stadium or event services.
INTAKE TESTING: Individuals in all tiers underwent multi-day tests in order to gain to access to the facility for training camp.
ONGOING MONITORING & SCREENING: Tier 1 and 2 individuals will continue to be tested daily into the regular season. Players will be tested the day before games to determine their eligibility to play. Tier 3 individuals are tested on a weekly basis.
Before any player or personnel was allowed access to club facilities for training camp, they underwent multi-day tests. Only individuals that tested negative for all tests conducted were allowed to enter the club facility.
Ongoing Monitoring Testing and Screening
Tier 1 and 2 individuals will continue to be tested daily into the regular season. Players will be tested the day before games to determine their eligibility to play. Tier 3 individuals are tested once per week.
Players on the COVID IR list include those who have tested positive for COVID-19 AND who have had a close contact exposure to someone with COVID-19. All players on the list are not diagnosed as positive for COVID-19.
++ Confirmatory Testing: If a player, Tier 1 or Tier 2 individual with no known history of COVID infection (as proved by a documented PCR test) receives a new positive test result and is asymptomatic then that individual shall receive two confirmatory tests on the day following the positive test result. The tested individual is immediately placed on the COVID IR list and must remain out of the facility and isolate at home until the confirmatory test results return. If both confirmatory tests are negative, then the individual is not considered COVID positive and may resume all normal activity, including access to the facility.
++ Screening: In addition to Ongoing Monitoring Testing, players and club staff will be thoroughly screened every time they enter a club facility. These individuals will undergo a temperature check and will be required to fill out a COVID-19 questionnaire, which asks if the individual has experienced any COVID-19 symptoms in the preceding 48 hours (e.g. cough, shortness of breath, sore throat, fever, etc.). The questionnaire also asks player and personnel if they have come into contact with anyone who has had, or been exposed to a positive COVID-19 individual in the past 14 days.
Prioritizing Public Health
Public health officials have confirmed the NFL-NFLPA testing and monitoring program will not impact test access for people who need them. The NFL communicates regularly with the CDC and laboratory and public health experts on this topic and has been given assurances that the program will not constrain testing resources or otherwise burden the public in any way.
While the NFL will not release individual test results to protect the privacy of players and personnel, the league will regularly share aggregated, anonymized data regarding positive cases in an effort to help public health officials and the scientific community at-large gain insights from the testing program. Given that large-scale testing of a geographically diverse and asymptomatic population has not yet been conducted, the NFL expects that its testing program could provide broad insights about spread of the virus and how public health interventions help mitigate risk.
An Evolving Protocol
The 2020 season will require flexibility and adaptability, especially in evolving health and safety protocols to meet the medical science. The NFL and NFLPA expect the current testing protocols to change as medical and scientific knowledge of the virus continues to grow. The NFL and NFLPA are in regular communication with public health experts, the CDC, and medical officials from other professional sports leagues, among others. The current protocols reflect learnings so far and will continue to be adapted as necessary in partnership with the NFLPA.